Our Science
Unleashing the Power of Cellular Medicine
We Are Transforming the Creation of Autologous Totipotent Cells from Somatic Cells While Erasing All Epigenetics Without Altering DNA.
The MygoGenesis™ proprietary process turns somatic cells to totipotent cells and then to almost any cell or tissue, faster, more reliably, more efficiently, and with none of the challenges of alternative methods. It holds great potential to revolutionize cell therapies, gene therapies, food and water testing, and regenerative medicine.
Stem cell therapies hold great promise to transform medical care but are confronting significant challenges to ensure their safe and effective use in the treatment of patients.
Technical Challenges in Stem Cell Reprogramming
Achieving safe and efficient reprogramming of cells into pluripotent stem cells still remains a technical challenge.
Scalability, Standardization, Reliability, Reproducibility & Sustainability
Lack of standard protocols, scaling of production, increasing yield, sustainability and ensuring reproducibility of results remain major challenges affecting the speed, quality and efficacy of treatments.
Safety
Immunogenicity and Autoimmunity, controls on gene expression, delivery vector risks, off-target and long-term effects, all can pose unique safety challenges.
Cost
Developing, manufacturing, and delivering stem cell therapies with current technologies can be extremely expensive, limiting access for many patients.
Ethical Concerns
The harvesting of embryonic stem cells raises ethical questions about the beginning of life and the destruction of embryos.
